Doctors say the high-tech health devices are also good at objectively measuring quality of life.

FOLFIRINOX chemotherapy extends survival by nearly 20 months after surgery.

Results strengthen the path forward for targeted cancer therapies.

We still don’t have cancer totally figured out, so now is not the time to reduce our efforts in the basic investigation of cancer biology.

Using molecular tests to select the most appropriate treatment leads to better outcomes.

Half of those treated with the experimental immunotherapy bb2121 no longer had detectable cancer.

This is the first treatment advance in 30 years for rhabdomyosarcoma.

California study showed that women were less likely to get aggressive treatment and more likely to die of cancer.

World’s largest cancer conference covers all aspects of treatment, care and survivorship.

LOXO-292 demonstrates durable antitumor activity in people with lung, thyroid and other cancers.